Direkt zum Inhalt

Khaled, Najib Ben ; Seidensticker, Max ; Ricke, Jens ; Mayerle, Julia ; Oehrle, Bettina ; Rössler, Daniel ; Teupser, Daniel ; Ehmer, Ursula ; Bitzer, Michael ; Waldschmidt, Dirk ; Fuchs, Martin ; Reuken, Philipp A. ; Lange, Christian M. ; Wege, Henning ; Kandulski, Arne ; Dechene, Alexander ; Venerito, Marino ; Berres, Marie-Luise ; Luedde, Tom ; Kubisch, Ilja ; Reiter, Florian P. ; De Toni, Enrico N.

Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol

Khaled, Najib Ben, Seidensticker, Max, Ricke, Jens, Mayerle, Julia, Oehrle, Bettina, Rössler, Daniel, Teupser, Daniel, Ehmer, Ursula, Bitzer, Michael , Waldschmidt, Dirk, Fuchs, Martin, Reuken, Philipp A., Lange, Christian M., Wege, Henning, Kandulski, Arne, Dechene, Alexander, Venerito, Marino, Berres, Marie-Luise, Luedde, Tom , Kubisch, Ilja, Reiter, Florian P. and De Toni, Enrico N. (2022) Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol. Future Oncology 18 (12), pp. 1423-1435.

Date of publication of this fulltext: 29 Feb 2024 13:02
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleFuture Oncology
Publisher:FUTURE MEDICINE LTD
Place of Publication:LONDON
Volume:18
Number of Issue or Book Chapter:12
Page Range:pp. 1423-1435
Date2022
InstitutionsMedicine > Lehrstuhl für Innere Medizin I
Identification Number
ValueType
10.2217/fon-2021-1261DOI
Keywordsatezolizumab; BCLC B; bevacizumab; hepatocellular carcinoma; immunotherapy; liver cancer; PD-L1; transarterial chemoembolization; VEGF
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgPartially
Item ID57732

Export bibliographical data

Owner only: item control page

nach oben